(Q34559568)

3 August 2017

title

Myelomeningocele in an infant with intrauterine exposure to efavirenz (English)

1 reference

3 August 2017

1 reference

1 reference

Akihiko Saitoh

1

1 reference

3 August 2017

Andrew D Hull

series ordinal

2

1 reference

3 August 2017

Patricia Franklin

series ordinal

3

1 reference

3 August 2017

Stephen A Spector

series ordinal

4

1 reference

3 August 2017

publication date

1 August 2005

1 reference

3 August 2017

published in

Journal of Perinatology

1 reference

3 August 2017

volume

25

1 reference

3 August 2017

issue

8

1 reference

3 August 2017

page(s)

555-556

1 reference

Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211343

Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211343

Myelomeningocele in a child with intrauterine exposure to efavirenz.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211343

Periconceptional exposure to efavirenz and neural tube defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211343

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211343

From the Food and Drug Administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7211343

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.JP.7211343

1 reference

Dimensions Publication ID

3 August 2017

1021900891

0 references

1 reference